.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The British Association for Sexual Health and HIV (BASHH) recently released the 2026 update for the management of non-gonococcal urethritis (NGU). Urethritis remains a significant clinical concern for men\'s health globally. Therefore, these updated recommendations provide critical insights into the etiology, diagnostic criteria, and therapeutic pathways for both acute and persistent presentations. Specifically, the guideline focuses on identifying the underlying infectious causes to ensure precision in antibiotic therapy.
Diagnosis of NGU relies on a combination of clinical history and objective evidence of inflammation. Clinicians must identify an excess of polymorphonuclear leucocytes in the anterior urethra of symptomatic patients. However, the 2026 guideline stresses that symptoms alone are insufficient for a definitive diagnosis. Consequently, practitioners should utilize Nucleic Acid Amplification Tests (NAATs) to identify specific pathogens. This approach directly improves clinical outcomes and significantly reduces the risk of transmission to sexual partners.
The primary organisms associated with NGU are Chlamydia trachomatis and Mycoplasma genitalium. Because M. genitalium often exhibits resistance to common antibiotics, determining the specific aetiology is vital. Additionally, non-infectious causes should be considered if pathogens are not detected. NAAT-based screening remains the gold standard for guiding treatment decisions and preventing potential complications like epididymo-orchitis.
Effective management of non-gonococcal urethritis requires both the patient and their sexual partners to complete a full course of treatment. Patients must abstain from all sexual intercourse until they finish their medication and follow-up. Furthermore, clinicians should provide clear health promotion advice to prevent re-infection. Following these behavioral protocols is as important as the pharmacological intervention itself to break the chain of infection.
The 2026 BASHH guidelines identify Chlamydia trachomatis and Mycoplasma genitalium as the most common infectious organisms. However, NGU can also stem from non-infectious triggers or other rare pathogens.
Patients should wait until they and their partners have completed the entire treatment course and any necessary follow-up. This ensures that the infection is fully eradicated and prevents immediate re-infection.
Testing for M. genitalium is crucial because this organism frequently develops resistance to macrolides. Therefore, identifying it through NAAT helps clinicians select the most effective antibiotic regimen from the start.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. While we strive for accuracy, medical knowledge is constantly evolving. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Summary of the 2026 BASHH guidelines on the management of non-gonococcal urethritis (NGU), including diagnosis, etiology, and treatment protocols....
6 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
